pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,161 catalysts · 5,159 phase readout · 2,326 8k filing · 316 pdufa · 275 earnings · 108 phase 2 completion · 50 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 31 catalysts2026-07-30: 13 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: approval×type: grant×type: phase readout×clear all
type
  • phase readout5,159
  • 8k filing2,326
  • pdufa316
  • earnings275
  • phase 2 completion108
  • phase 1 completion50
phase 1 2 completion
28
  • phase 1 initiation22
  • phase 0 trial completion21
  • phase 1 2 initiation9
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›RECRUITINGphase readoutNCT07052513: Modified Autologous Leukocyte Cells for the Treatment of Acute Kidney Injury After Cardiac Surgery

    Sponsor: M2RLAB SL. Phase: PHASE2. Conditions: Acute Kidney Injury

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07330713: Platelet-Rich Plasma for Acute Nonarteritic Anterior Ischemic Optic Neuropathy: A Prospective Randomized Controlled Study

    Sponsor: Uludag University. Phase: NA. Conditions: Nonarteritic Anterior Ischemic Optic Neuropathy

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02462460: Rapid Pancreatic and Ovarian Screening MR Imaging With Motion Corrected T1, T2, and Advanced Diffusion Weighted Imaging for Patients With BRCA Mutation Who Undergo Screening Breast MRI

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: . Conditions: Screening Breast MRI in Patients Who Are BRCA Mutation Carriers

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07585760: CM336 Plus Isatuximab for Newly Diagnosed Multiple Myeloma With Renal Impairment

    Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: PHASE2. Conditions: Multiple Myeloma (MM), Multiple Myeloma Light Chain Induced Renal Insufficiency

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07729020: Effectiveness of Virtual Reality in Reducing Anxiety and Pain During the First Postoperative Orthopedic Dressing Change in Pediatric Patients

    Sponsor: Gianluca Catania. Phase: NA. Conditions: Anxiety, Pain, Post Operative

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07471620: The Effect of High Intensity Functional Exercise Programs on Menopausal Symptoms, Physical Performance, and Dual Task Performance in Postmenopausal Women

    Sponsor: Uskudar University. Phase: NA. Conditions: Postmenopausal Period

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07528820: Inflammatory Profiles, Histopathological Features, and Remodeling Factors in Chronic Rhinosinusitis With Nasal Polyps

    Sponsor: St. Paul's Sinus Centre. Phase: NA. Conditions: CRSwNP, Chronic Rhinosinusitis (Diagnosis), Nasal Polyposis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04142320: Closed-loop Optimized rTMS for Depression

    Sponsor: Stanford University. Phase: PHASE1. Conditions: Major Depressive Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07372820: METABolic Deterioration in HTX Determines Outcomes

    Sponsor: Heinrich-Heine University, Duesseldorf. Phase: . Conditions: Heart Transplantation

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07362524: AI-Assisted Real-Time Endoscopic Characterization of Diminutive Colorectal Polyps in Non-Academic Hospitals

    Sponsor: Shanghai Jiao Tong University School of Medicine. Phase: NA. Conditions: Colorectal Polyps

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06912724: Pediatric Neuroimaging

    Sponsor: National Institute on Aging (NIA). Phase: . Conditions: Neurogimaging

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05987696: Natural Killer(NK) Cell Therapy in Acute Myeloid Leukemia

    Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: PHASE1. Conditions: AML, Adult, Minimal Residual Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04301596: Assessment of Nutritional Status in Systemic Sclerosis

    Sponsor: University Hospital, Montpellier. Phase: . Conditions: Systemic Sclerosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06840496: To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome

    Sponsor: Biomed Industries, Inc.. Phase: PHASE3. Conditions: Rett Syndrome

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07228962: Cutaneous Biomarkers in Atopic Eczema Using a Non-Invasive Micro-Suction Device in Babies

    Sponsor: King's College London. Phase: . Conditions: Eczema, Atopic Dermatitis, Atopic Eczema

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06545162: Safety, Tolerability, and Pharmacokinetics of a Single or Multiple Ascending Doses of CPX101

    Sponsor: Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Overweight and Obesity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06639503: Genicular Nerve Block After Open Reduction Internal Fixation of Tibial Plateau

    Sponsor: University of Chicago. Phase: PHASE1. Conditions: Tibial Plateau Fractures

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06384261: A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy

    Sponsor: OncoVerity, Inc.. Phase: PHASE2. Conditions: Leukemia, Myeloid, Acute

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05497427: Normative Database and Test-Retest Reliability for BrainCheck Assessments

    Sponsor: BrainCheck, Inc.. Phase: . Conditions: Cognitive Change, Cognitive Decline, Cognitive Deterioration, Neurocognitive Deficit

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06687070: APG-2449 Monotherapy or in Combination With PLD in Patients With Platinum-resistant Recurrent OC or Advanced ST

    Sponsor: Ascentage Pharma Group Inc.. Phase: PHASE1. Conditions: Platinum-resistant Recurrent Ovarian Cancer, Advanced Solid Tumor

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04789070: Phase III Trial of Sirolimus in IBM

    Sponsor: University of Kansas Medical Center. Phase: PHASE3. Conditions: Inclusion Body Myositis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04302870: Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised Trial

    Sponsor: University of Edinburgh. Phase: PHASE2. Conditions: Motor Neuron Disease, Amyotrophic Lateral Sclerosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05796570: A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies

    Sponsor: Franziska Wachter. Phase: PHASE2. Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes, Myeloid Malignancies, MDS, Inherited Bone Marrow Failure Syndrome, Myeloid Neoplasm, Aml

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT04869670: A Study to Evaluate Safety and Effectiveness of G-POEM for Gastroparesis

    Sponsor: Mayo Clinic. Phase: NA. Conditions: Gastroparesis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05756270: Clinical Applicability of pCASL as a Substitute for FDG-PET in MCI and SCD Patients

    Sponsor: University of Milano Bicocca. Phase: . Conditions: Mild Cognitive Impairment, Subjective Cognitive Decline

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07445373: Role of the WHO Labour Care Guide in Improving Maternal and Fetal Outcomes

    Sponsor: Khyber Teaching Hospital. Phase: NA. Conditions: Labor and Delivery

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06651073: ATTR-CM: A Multi-country, Non-interventional Disease Registry

    Sponsor: Pfizer. Phase: . Conditions: Transthyretin Amyloid Cardiopathy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06870669: The Effect of Progressive Relaxation Exercises by Nursing Students Before Clinical Practice

    Sponsor: Manisa Celal Bayar University. Phase: NA. Conditions: Healthy, Stress, Exercise

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07663773: Thyroid Hormones in CKD

    Sponsor: Mario Negri Institute for Pharmacological Research. Phase: . Conditions: Chronic Kidney Disease (Stages 4 and 5)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07233655: A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid Arthritis

    Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd. Phase: PHASE2. Conditions: Moderate to Severe Active Rheumatoid Arthritis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07243626: Efficacy and Safety of Envafolimab Plus Doxorubicin and Ifosfamide for Advanced Soft Tissue Sarcoma

    Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University. Phase: PHASE2. Conditions: Soft Tissue Sarcoma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07430826: Building Opportunities for Nurturing Care to Enhance Child Development in Eastern and Southern Africa

    Sponsor: University of Washington. Phase: NA. Conditions: Neurodevelopment, Child Growth

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03448926: The PREDICT Registry:

    Sponsor: PreludeDx. Phase: . Conditions: DCIS, Stage 0 Breast Cancer, Ductal Breast Carcinoma In Situ

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07224178: Left Atrial Strain and Cryptogenic Stroke

    Sponsor: University of Pittsburgh. Phase: . Conditions: Ischemic Stroke, Cryptogenic, Ischemic Stroke, Embolic, Hemorrhagic Stroke, Embolic Stroke of Undetermined Source, Recurrent Ischemic Stroke

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07489378: NCI Childhood Cancer Data Initiative (CCDI) Led Pediatric, Adolescent, and Young Adult Rare Cancer Registry for Very Rare Solid Tumors

    Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Very Rare Tumors, Very Rare Cancers, Other Solid Tumors, Solid Tumor, Pediatric Rare Tumors

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03123978: Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate Cancer

    Sponsor: University of California, Davis. Phase: PHASE1. Conditions: Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07586748: Pressure Ulcer Development Device Related

    Sponsor: Assuta Medical Center. Phase: . Conditions: Pressure Ulcer, Pressure Ulcer Prevention, Venous Thrombosis Deep (Limbs)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07703748: Long-Term Real-World Evidence Study to Evaluate Effectiveness, Persistence, Adherence, Safety and Tolerability of Long-acting Cabotegravir Plus Rilpivirine.

    Sponsor: FUNDACIÓN HOSPITAL UNIVERSITARIO INFANTA LEONOR Y DEL HOSPITAL UNIVERSITARIO DEL SURESTE. Phase: . Conditions: Human Immunodeficiency Virus Infection (HIV), HIV-1 Infection in Adults

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07331948: INFLUENCE OF VOJTA THERAPY IN CEREBRAL PALSY. INFANTILE HEMIPARESIS

    Sponsor: Centro Integral Kaplan. Phase: NA. Conditions: Pediatric Hemiparesis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07319455: Heart Voice: Starry Journey - A Digital ACT Intervention for ASD Caregivers

    Sponsor: Harbin Medical University. Phase: NA. Conditions: Autism Spectrum Disorder

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07490626: At-Home Paracentesis for Women With Cancer-Related Malignant Ascites (Paracentesis)

    Sponsor: University of Utah. Phase: NA. Conditions: Malignant Ascites

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03069378: A Study of Talimogene Laherparepvec (T-VEC) in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Sarcoma, Epithelioid Sarcoma, Cutaneous Angiosarcoma

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT07251985: Cognitive Effects of Bioavailable Curcumin

    Sponsor: University of California, Los Angeles. Phase: PHASE2. Conditions: Memory, Cognitive Function Decline

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07398885: Assessing the Impact of Herbal Supplement on Fatigue and Disease Activity in SLE: Results From an 8-Week Randomized Trial

    Sponsor: University Tunis El Manar. Phase: NA. Conditions: System; Lupus Erythematosus

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07709585: Befotertinib Plus Chemotherapy With an MRD-guided Adaptive Strategy for Treatment Escalation and Response Optimization in EGFR-mutated NSCLC Patients

    Sponsor: Guangzhou University of Traditional Chinese Medicine. Phase: PHASE2. Conditions: Advanced Non-small Cell Lung Cancer (NSCLC), EGFR Exon 19 Deletion Mutation, EGFR Exon 21 Mutation, EGFR Exon 21 L858R Mutation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03391778: Adoptive Cell Therapy Long-term Follow-up (LTFU) Study

    Sponsor: USWM CT, LLC. Phase: PHASE1. Conditions: Neoplasms

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06405555: Midodrine in Heart Failure With Reduced Ejection Fraction With Hypotension

    Sponsor: Ottawa Heart Institute Research Corporation. Phase: PHASE2. Conditions: Heart Failure With Reduced Ejection Fraction, Hypotension, LV Dysfunction

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07676955: Dexmedetomidine Versus Ketamine Loading for Dexmedetomidine Sedation During Elective Cesarean Section Under Spinal Anesthesia

    Sponsor: Haseki Training and Research Hospital. Phase: PHASE4. Conditions: Cesarean Birth, Spinal Anesthesia, Sedation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04377555: Prospective Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) After Initiation and During Treatment With Ocrelizumab

    Sponsor: Genentech, Inc.. Phase: PHASE4. Conditions: Multiple Sclerosis, Relapsing

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07725926: Integrating Exposure and Response Prevention and Habit Reversal Techniques to Treat a Tourettic Subtype of Obsessive-Compulsive Disorder (Tourettic OCD)

    Sponsor: University College London Hospitals. Phase: NA. Conditions: Obsessive - Compulsive Disorder, Tic Disorder, Chronic Motor or Vocal, Tic Disorders, Tic Disorder, Combined Vocal and Multiple Motor, Tourette Disease, Tourette Disorder, Tourettes Syndrome, Gilles de la Tourette Syndrome

    full page →ctgov ↗
    ← prev
    page 99 of 104
    next →